Thyroid function, autoimmunity, thyroid volume, and metabolic profile in people with Hashimoto thyroiditis.

IF 2.8 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM
Bruna Couto, Celestino Neves, João Sérgio Neves, Luís Delgado
{"title":"Thyroid function, autoimmunity, thyroid volume, and metabolic profile in people with Hashimoto thyroiditis.","authors":"Bruna Couto, Celestino Neves, João Sérgio Neves, Luís Delgado","doi":"10.1186/s12902-024-01765-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hashimoto's thyroiditis (HT) is associated with high cardiovascular risk. Thyroid volume has a notable dispersion of values in these patients. This study aims to clarify the association between thyroid antibodies, thyroid morphology, insulin resistance, and lipid profile in patients with HT.</p><p><strong>Methods: </strong>Cross-sectional study that includes 409 subjects diagnosed with HT. We assessed thyroid function, markers of autoimmunity, and markers of cardiovascular risk. We also evaluated thyroid ultrasound and studied the correlation between all factors.</p><p><strong>Results: </strong>Among the study population, 9.8% were male, the mean age was 56.4 ± 17.4 years, 63.7% had dyslipidemia, and 29.5% had diabetes. Patients with hypothyroidism had higher levels of anti-thyroperoxidase antibodies (TPOab), and the decreased thyroid dimensions subgroup had a higher percentage of patients taking levothyroxine (98.7%). Positive correlations were found between TPOab and volume, and negative correlations were observed between thyroid-stimulating hormone (TSH) and volume.</p><p><strong>Conclusion: </strong>The current study reveals a complex interrelationship between cardiovascular disease risk factors, thyroid function, autoimmunity, and thyroid volume in HT. These associations may be of clinical relevance, and further studies are needed to elucidate how these findings may be used clinically to reduce the cardiovascular risk in patients with HT.</p>","PeriodicalId":9152,"journal":{"name":"BMC Endocrine Disorders","volume":"24 1","pages":"281"},"PeriodicalIF":2.8000,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11687027/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Endocrine Disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12902-024-01765-4","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Hashimoto's thyroiditis (HT) is associated with high cardiovascular risk. Thyroid volume has a notable dispersion of values in these patients. This study aims to clarify the association between thyroid antibodies, thyroid morphology, insulin resistance, and lipid profile in patients with HT.

Methods: Cross-sectional study that includes 409 subjects diagnosed with HT. We assessed thyroid function, markers of autoimmunity, and markers of cardiovascular risk. We also evaluated thyroid ultrasound and studied the correlation between all factors.

Results: Among the study population, 9.8% were male, the mean age was 56.4 ± 17.4 years, 63.7% had dyslipidemia, and 29.5% had diabetes. Patients with hypothyroidism had higher levels of anti-thyroperoxidase antibodies (TPOab), and the decreased thyroid dimensions subgroup had a higher percentage of patients taking levothyroxine (98.7%). Positive correlations were found between TPOab and volume, and negative correlations were observed between thyroid-stimulating hormone (TSH) and volume.

Conclusion: The current study reveals a complex interrelationship between cardiovascular disease risk factors, thyroid function, autoimmunity, and thyroid volume in HT. These associations may be of clinical relevance, and further studies are needed to elucidate how these findings may be used clinically to reduce the cardiovascular risk in patients with HT.

桥本甲状腺炎患者的甲状腺功能、自身免疫、甲状腺体积和代谢特征
背景:桥本甲状腺炎(桥本甲状腺炎)与高心血管风险相关。甲状腺体积值在这些患者中有明显的离散性。本研究旨在阐明HT患者甲状腺抗体、甲状腺形态、胰岛素抵抗和血脂之间的关系。方法:横断面研究,包括409名诊断为HT的受试者。我们评估了甲状腺功能、自身免疫标志物和心血管风险标志物。我们还评估了甲状腺超声,并研究了各因素之间的相关性。结果:研究人群中男性占9.8%,平均年龄(56.4±17.4)岁,血脂异常63.7%,糖尿病29.5%。甲状腺功能减退患者抗甲状腺过氧化物酶抗体(TPOab)水平较高,甲状腺尺寸减小亚组服用左甲状腺素的患者比例较高(98.7%)。TPOab与体积呈正相关,TSH与体积呈负相关。结论:目前的研究揭示了HT患者心血管疾病危险因素、甲状腺功能、自身免疫和甲状腺体积之间复杂的相互关系。这些关联可能具有临床相关性,需要进一步的研究来阐明这些发现如何在临床上用于降低HT患者的心血管风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMC Endocrine Disorders
BMC Endocrine Disorders ENDOCRINOLOGY & METABOLISM-
CiteScore
4.40
自引率
0.00%
发文量
280
审稿时长
>12 weeks
期刊介绍: BMC Endocrine Disorders is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of endocrine disorders, as well as related molecular genetics, pathophysiology, and epidemiology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信